Tampa, Fla.-based Moffitt Cancer Center recorded an operating income of $62.5 million (7.4% operating margin) in the second quarter of 2026, up from an operating income of $28.2 million (3.8% margin) during the same period last year, according to its Feb. 9 financial report.
For the three months ended Dec. 31, Moffitt reported total operating revenue of $849.6 million, up from $736 million during the same period last year. Patient service revenue was $736.8 million, up from $641.4 million.
Total expenses were $787.1 million in the quarter, up from $707.8 million last year. Salaries, wages and benefits totaled $365.5 million, up from $315.8 million. Supply expenses were $293 million, up from $274.8 million. Other operating expenses were $33.2 million, down from $37.2 million.
Moffitt recorded a net income of $84.3 million in the second quarter of 2025, up from $22.9 million during the same quarter last year.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
